Novartis AG Sponsored ADR
Brak transakcji
Brak transakcji
Korporacyjne papiery dłużne
Poniżej znajduje się lista obligacji Novartis AG Sponsored ADR, posortowana według wskaźnika yield to worst. Inwestorzy często wybierają obligacje spółek ze względu na ich większą stabilność w okresach zmienności rynkowej. Analizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTW % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Rating S&P | Ocena kredytowa Fitch | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| NNVS6224266Novartis Capital Corp. 5.3% 05-NOV-2055 | 5,98% | 90,61% | 5,300% | 2055-11-05 | 550 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342132Novartis Capital Corp. 5.7% 18-MAR-2056 | 5,95% | 96,42% | 5,700% | 2056-03-18 | 2,25 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5,93% | 83,22% | 4,700% | 2054-09-18 | 750 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342130Novartis Capital Corp. 5.6% 18-MAR-2046 | 5,90% | 96,48% | 5,600% | 2046-03-18 | 1 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAS7Novartis Capital Corp. 2.75% 14-AUG-2050 | 5,87% | 60,06% | 2,750% | 2050-08-14 | 1,25 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224265Novartis Capital Corp. 5.2% 05-NOV-2045 | 5,80% | 93,00% | 5,200% | 2045-11-05 | 350 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAH1Novartis Capital Corp. 4.4% 06-MAY-2044 | 5,80% | 84,63% | 4,400% | 2044-05-06 | 1,85 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| XXPNDNovartis Capital Corp. 4.0% 20-NOV-2045 | 5,79% | 79,33% | 4,000% | 2045-11-20 | 1,25 B USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5,68% | 79,23% | 3,700% | 2042-09-21 | 500 M USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS6342131Novartis Capital Corp. 4.9% 18-MAR-2036 | 5,31% | 96,94% | 4,900% | 2036-03-18 | 2,25 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224264Novartis Capital Corp. 4.6% 05-NOV-2035 | 5,23% | 95,44% | 4,600% | 2035-11-05 | 925 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5,06% | 94,30% | 4,200% | 2034-09-18 | 1,1 B USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS6342137Novartis Capital Corp. 4.6% 18-MAR-2033 | 5,05% | 97,47% | 4,600% | 2033-03-18 | 2 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224263Novartis Capital Corp. 4.3% 05-NOV-2032 | 4,89% | 96,83% | 4,300% | 2032-11-05 | 925 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342136Novartis Capital Corp. 4.4% 18-MAR-2031 | 4,84% | 98,22% | 4,400% | 2031-03-18 | 1,75 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224251Novartis Capital Corp. 4.1% 05-NOV-2030 | 4,79% | 97,38% | 4,100% | 2030-11-05 | 1,75 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAR9Novartis Capital Corp. 2.2% 14-AUG-2030 | 4,72% | 90,95% | 2,200% | 2030-08-14 | 1,5 B USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4,71% | 96,81% | 4,000% | 2031-09-18 | 850 M USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4,55% | 97,85% | 3,800% | 2029-09-18 | 1 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342135Novartis Capital Corp. 4.1% 16-MAR-2029 | 4,53% | 98,97% | 4,100% | 2029-03-16 | 1,25 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224255Novartis Capital Corp. 3.9% 05-NOV-2028 | 4,45% | 98,84% | 3,900% | 2028-11-05 | 700 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAN8Novartis Capital Corp. 3.1% 17-MAY-2027 | 4,14% | 99,28% | 3,100% | 2027-05-17 | 1 B USD | 1 000,00 USD | AA− | AA- | Novartis Capital Corp. |
| XXS336624860Novartis Finance S.A. 4.0% 13-MAY-2041 | 4,10% | 98,90% | 4,000% | 2041-05-13 | 500 M EUR | 1 000,00 EUR | AA− | — | Novartis Finance SA |
| NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 3,98% | 99,05% | 2,000% | 2027-02-14 | 1,25 B USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| XXS176904160Novartis Finance S.A. 1.7% 14-AUG-2038 | 3,77% | 80,36% | 1,700% | 2038-08-14 | 750 M EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
| XXS336624851Novartis Finance S.A. 3.5% 13-MAY-2035 | 3,76% | 98,04% | 3,500% | 2035-05-13 | 600 M EUR | 1 000,00 EUR | AA− | — | Novartis Finance SA |
| XXS336624827Novartis Finance S.A. 3.1% 13-JAN-2032 | 3,47% | 98,19% | 3,100% | 2032-01-13 | 600 M EUR | 1 000,00 EUR | AA− | — | Novartis Finance SA |
| XXS149282548Novartis Finance S.A. 0.625% 20-SEP-2028 | 3,14% | 95,03% | 0,625% | 2028-09-20 | 500 M EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
| XXS176904119Novartis Finance S.A. 1.375% 14-AUG-2030 | 3,12% | 93,55% | 1,375% | 2030-08-14 | 750 M EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
| XXS113472979Novartis Finance S.A. 1.625% 09-NOV-2026 | 2,72% | 99,77% | 1,625% | 2026-11-09 | 600 M EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
| NNOJANovartis Finance S.A. 1.125% 30-SEP-2027 | 2,72% | 98,29% | 1,125% | 2027-09-30 | 600 M EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
 NOV245Novartis AG 1.85% 18-JUN-2049 | 1,45% | 107,60% | 1,850% | 2049-06-18 | 190 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| NOV244Novartis AG 1.85% 18-JUN-2040 | 1,33% | 106,53% | 1,850% | 2040-06-18 | 280 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| NOV152Novartis AG 1.05% 11-MAY-2035 | 1,05% | 100,03% | 1,050% | 2035-05-11 | 325 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| CH135325782Novartis AG 1.75% 16-JUN-2034 | 0,98% | 105,72% | 1,750% | 2034-06-16 | 645 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| A3LZ2RNovartis AG 1.65% 18-JUN-2031 | 0,79% | 104,07% | 1,650% | 2031-06-18 | 435 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| NOV151Novartis AG 0.625% 13-NOV-2029 | 0,62% | 100,03% | 0,625% | 2029-11-13 | 550 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| CH135325780Novartis AG 1.6% 18-JUN-2027 | 0,22% | 101,12% | 1,600% | 2027-06-18 | 650 M CHF | 5 000,00 CHF | AA− | AA- | Novartis AG |
| NNVS6342134Novartis Capital Corp. FRN 16-MAR-2029 | — | 100,45% | 4,288% | 2029-03-16 | 500 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |
| XXS223599621Novartis Finance S.A. 0.0% 23-SEP-2028 | — | 93,80% | 0,000% | 2028-09-23 | 1,85 B EUR | 1 000,00 EUR | AA− | AA- | Novartis Finance SA |
| NNVS6224271Novartis Capital Corp. FRN 05-NOV-2028 | — | 100,07% | 4,156% | 2028-11-05 | 800 M USD | 1 000,00 USD | AA− | — | Novartis Capital Corp. |